Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough
Leuk Lymphoma. 2025 Jun 22:1-5.
doi: 10.1080/10428194.2025.2519921.
Online ahead of print.